nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—multiple sclerosis—amyotrophic lateral sclerosis	0.585	1	CtDrD
Dexamethasone—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.11	0.52	CbGbCtD
Dexamethasone—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.102	0.48	CbGbCtD
Dexamethasone—PTGS2—amyotrophic lateral sclerosis	0.0834	1	CbGaD
Dexamethasone—Personality change—Riluzole—amyotrophic lateral sclerosis	0.00412	0.0746	CcSEcCtD
Dexamethasone—Panophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.00324	0.0586	CcSEcCtD
Dexamethasone—Osteonecrosis—Riluzole—amyotrophic lateral sclerosis	0.00212	0.0384	CcSEcCtD
Dexamethasone—Endophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.00166	0.0301	CcSEcCtD
Dexamethasone—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.00141	0.0255	CcSEcCtD
Dexamethasone—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00128	0.0233	CcSEcCtD
Dexamethasone—Embolism—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0223	CcSEcCtD
Dexamethasone—ANXA1—nerve—amyotrophic lateral sclerosis	0.00121	0.0661	CbGeAlD
Dexamethasone—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00112	0.0202	CcSEcCtD
Dexamethasone—Mania—Riluzole—amyotrophic lateral sclerosis	0.00109	0.0197	CcSEcCtD
Dexamethasone—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00106	0.0192	CcSEcCtD
Dexamethasone—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00105	0.019	CcSEcCtD
Dexamethasone—Abscess—Riluzole—amyotrophic lateral sclerosis	0.000999	0.0181	CcSEcCtD
Dexamethasone—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.000975	0.0177	CcSEcCtD
Dexamethasone—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00096	0.0174	CcSEcCtD
Dexamethasone—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.000899	0.0163	CcSEcCtD
Dexamethasone—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.000869	0.0157	CcSEcCtD
Dexamethasone—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.000841	0.0152	CcSEcCtD
Dexamethasone—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.000835	0.0151	CcSEcCtD
Dexamethasone—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00083	0.015	CcSEcCtD
Dexamethasone—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00079	0.0143	CcSEcCtD
Dexamethasone—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.000781	0.0141	CcSEcCtD
Dexamethasone—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00075	0.0136	CcSEcCtD
Dexamethasone—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.000714	0.0129	CcSEcCtD
Dexamethasone—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.000703	0.0127	CcSEcCtD
Dexamethasone—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.000679	0.0123	CcSEcCtD
Dexamethasone—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.000659	0.0119	CcSEcCtD
Dexamethasone—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.000632	0.0115	CcSEcCtD
Dexamethasone—Injury—Riluzole—amyotrophic lateral sclerosis	0.000624	0.0113	CcSEcCtD
Dexamethasone—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.000611	0.0111	CcSEcCtD
Dexamethasone—PTGS2—hindlimb—amyotrophic lateral sclerosis	0.000599	0.0327	CbGeAlD
Dexamethasone—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.000593	0.0107	CcSEcCtD
Dexamethasone—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.000588	0.0106	CcSEcCtD
Dexamethasone—NR3C2—hindbrain—amyotrophic lateral sclerosis	0.000587	0.0321	CbGeAlD
Dexamethasone—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.000574	0.0104	CcSEcCtD
Dexamethasone—ANXA1—embryo—amyotrophic lateral sclerosis	0.000567	0.031	CbGeAlD
Dexamethasone—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.000565	0.0102	CcSEcCtD
Dexamethasone—Migraine—Riluzole—amyotrophic lateral sclerosis	0.000565	0.0102	CcSEcCtD
Dexamethasone—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00056	0.0101	CcSEcCtD
Dexamethasone—PGR—hindbrain—amyotrophic lateral sclerosis	0.000546	0.0298	CbGeAlD
Dexamethasone—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.000545	0.00988	CcSEcCtD
Dexamethasone—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.000543	0.00984	CcSEcCtD
Dexamethasone—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.000522	0.00945	CcSEcCtD
Dexamethasone—PTGS2—appendage—amyotrophic lateral sclerosis	0.000514	0.028	CbGeAlD
Dexamethasone—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.000506	0.00916	CcSEcCtD
Dexamethasone—Fluocinolone Acetonide—PLA2G4A—amyotrophic lateral sclerosis	0.000476	0.507	CrCbGaD
Dexamethasone—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000451	0.00817	CcSEcCtD
Dexamethasone—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000449	0.00812	CcSEcCtD
Dexamethasone—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.000436	0.00789	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000433	0.00785	CcSEcCtD
Dexamethasone—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.000433	0.00785	CcSEcCtD
Dexamethasone—NR3C1—nerve—amyotrophic lateral sclerosis	0.000421	0.023	CbGeAlD
Dexamethasone—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000404	0.00732	CcSEcCtD
Dexamethasone—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.000399	0.00722	CcSEcCtD
Dexamethasone—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000397	0.00719	CcSEcCtD
Dexamethasone—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000395	0.00715	CcSEcCtD
Dexamethasone—NR0B1—brain—amyotrophic lateral sclerosis	0.000382	0.0209	CbGeAlD
Dexamethasone—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000371	0.00672	CcSEcCtD
Dexamethasone—ANXA1—medulla oblongata—amyotrophic lateral sclerosis	0.000363	0.0198	CbGeAlD
Dexamethasone—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00036	0.00652	CcSEcCtD
Dexamethasone—PLA2G1B—nervous system—amyotrophic lateral sclerosis	0.000356	0.0194	CbGeAlD
Dexamethasone—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000354	0.00642	CcSEcCtD
Dexamethasone—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000351	0.00635	CcSEcCtD
Dexamethasone—PLA2G1B—central nervous system—amyotrophic lateral sclerosis	0.000343	0.0187	CbGeAlD
Dexamethasone—NR3C2—brainstem—amyotrophic lateral sclerosis	0.000337	0.0184	CbGeAlD
Dexamethasone—Fluticasone Propionate—PLA2G4A—amyotrophic lateral sclerosis	0.000325	0.346	CrCbGaD
Dexamethasone—CYP17A1—medulla oblongata—amyotrophic lateral sclerosis	0.000325	0.0177	CbGeAlD
Dexamethasone—ANXA1—spinal cord—amyotrophic lateral sclerosis	0.000323	0.0176	CbGeAlD
Dexamethasone—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000321	0.0058	CcSEcCtD
Dexamethasone—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000316	0.00572	CcSEcCtD
Dexamethasone—NR3C1—hindbrain—amyotrophic lateral sclerosis	0.000315	0.0172	CbGeAlD
Dexamethasone—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000312	0.00564	CcSEcCtD
Dexamethasone—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00031	0.00562	CcSEcCtD
Dexamethasone—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00031	0.00561	CcSEcCtD
Dexamethasone—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000304	0.0055	CcSEcCtD
Dexamethasone—CYP11A1—medulla oblongata—amyotrophic lateral sclerosis	0.000302	0.0165	CbGeAlD
Dexamethasone—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000299	0.00542	CcSEcCtD
Dexamethasone—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000298	0.0054	CcSEcCtD
Dexamethasone—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000294	0.00533	CcSEcCtD
Dexamethasone—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000293	0.00531	CcSEcCtD
Dexamethasone—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000291	0.00526	CcSEcCtD
Dexamethasone—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000282	0.00511	CcSEcCtD
Dexamethasone—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000282	0.00511	CcSEcCtD
Dexamethasone—Infection—Riluzole—amyotrophic lateral sclerosis	0.00028	0.00507	CcSEcCtD
Dexamethasone—Shock—Riluzole—amyotrophic lateral sclerosis	0.000277	0.00502	CcSEcCtD
Dexamethasone—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000276	0.00501	CcSEcCtD
Dexamethasone—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000276	0.005	CcSEcCtD
Dexamethasone—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000275	0.00498	CcSEcCtD
Dexamethasone—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000273	0.00494	CcSEcCtD
Dexamethasone—ANXA1—nervous system—amyotrophic lateral sclerosis	0.000272	0.0149	CbGeAlD
Dexamethasone—PLA2G1B—brain—amyotrophic lateral sclerosis	0.000272	0.0149	CbGeAlD
Dexamethasone—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000269	0.00487	CcSEcCtD
Dexamethasone—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000263	0.00477	CcSEcCtD
Dexamethasone—ANXA1—central nervous system—amyotrophic lateral sclerosis	0.000262	0.0143	CbGeAlD
Dexamethasone—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000257	0.00465	CcSEcCtD
Dexamethasone—ANXA1—cerebellum—amyotrophic lateral sclerosis	0.000256	0.014	CbGeAlD
Dexamethasone—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000255	0.00462	CcSEcCtD
Dexamethasone—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000253	0.00458	CcSEcCtD
Dexamethasone—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000248	0.00449	CcSEcCtD
Dexamethasone—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000245	0.00444	CcSEcCtD
Dexamethasone—CYP17A1—nervous system—amyotrophic lateral sclerosis	0.000244	0.0133	CbGeAlD
Dexamethasone—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000243	0.00441	CcSEcCtD
Dexamethasone—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000243	0.0044	CcSEcCtD
Dexamethasone—Pain—Riluzole—amyotrophic lateral sclerosis	0.000241	0.00437	CcSEcCtD
Dexamethasone—CYP17A1—central nervous system—amyotrophic lateral sclerosis	0.000235	0.0128	CbGeAlD
Dexamethasone—NR3C2—medulla oblongata—amyotrophic lateral sclerosis	0.000235	0.0128	CbGeAlD
Dexamethasone—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000234	0.0128	CbGeAlD
Dexamethasone—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000232	0.00421	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000231	0.00418	CcSEcCtD
Dexamethasone—CYP11A1—nervous system—amyotrophic lateral sclerosis	0.000227	0.0124	CbGeAlD
Dexamethasone—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000224	0.00406	CcSEcCtD
Dexamethasone—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000223	0.00404	CcSEcCtD
Dexamethasone—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000223	0.00404	CcSEcCtD
Dexamethasone—CYP11A1—central nervous system—amyotrophic lateral sclerosis	0.000219	0.0119	CbGeAlD
Dexamethasone—NR3C2—spinal cord—amyotrophic lateral sclerosis	0.000209	0.0114	CbGeAlD
Dexamethasone—ANXA1—brain—amyotrophic lateral sclerosis	0.000208	0.0114	CbGeAlD
Dexamethasone—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000202	0.00366	CcSEcCtD
Dexamethasone—SLCO1A2—medulla oblongata—amyotrophic lateral sclerosis	0.000201	0.011	CbGeAlD
Dexamethasone—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000199	0.00361	CcSEcCtD
Dexamethasone—NR3C1—embryo—amyotrophic lateral sclerosis	0.000197	0.0108	CbGeAlD
Dexamethasone—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000193	0.00349	CcSEcCtD
Dexamethasone—CYP17A1—brain—amyotrophic lateral sclerosis	0.000187	0.0102	CbGeAlD
Dexamethasone—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000186	0.00338	CcSEcCtD
Dexamethasone—NR3C1—brainstem—amyotrophic lateral sclerosis	0.000181	0.00986	CbGeAlD
Dexamethasone—SLCO1A2—spinal cord—amyotrophic lateral sclerosis	0.000179	0.00979	CbGeAlD
Dexamethasone—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000179	0.00325	CcSEcCtD
Dexamethasone—Rash—Riluzole—amyotrophic lateral sclerosis	0.000178	0.00322	CcSEcCtD
Dexamethasone—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000178	0.00322	CcSEcCtD
Dexamethasone—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.000177	0.00967	CbGeAlD
Dexamethasone—Headache—Riluzole—amyotrophic lateral sclerosis	0.000177	0.0032	CcSEcCtD
Dexamethasone—NR3C2—nervous system—amyotrophic lateral sclerosis	0.000176	0.00963	CbGeAlD
Dexamethasone—CYP11A1—brain—amyotrophic lateral sclerosis	0.000174	0.00948	CbGeAlD
Dexamethasone—PTGS2—embryo—amyotrophic lateral sclerosis	0.000171	0.00931	CbGeAlD
Dexamethasone—NR3C2—central nervous system—amyotrophic lateral sclerosis	0.00017	0.00927	CbGeAlD
Dexamethasone—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000167	0.00303	CcSEcCtD
Dexamethasone—NR3C2—cerebellum—amyotrophic lateral sclerosis	0.000166	0.00906	CbGeAlD
Dexamethasone—PGR—nervous system—amyotrophic lateral sclerosis	0.000164	0.00895	CbGeAlD
Dexamethasone—PGR—central nervous system—amyotrophic lateral sclerosis	0.000158	0.00862	CbGeAlD
Dexamethasone—PGR—cerebellum—amyotrophic lateral sclerosis	0.000154	0.00842	CbGeAlD
Dexamethasone—SLCO1A2—nervous system—amyotrophic lateral sclerosis	0.000151	0.00825	CbGeAlD
Dexamethasone—CYP19A1—nervous system—amyotrophic lateral sclerosis	0.000148	0.00805	CbGeAlD
Dexamethasone—SLCO1A2—central nervous system—amyotrophic lateral sclerosis	0.000146	0.00795	CbGeAlD
Dexamethasone—CYP2A6—brain—amyotrophic lateral sclerosis	0.000144	0.00785	CbGeAlD
Dexamethasone—SLCO1A2—cerebellum—amyotrophic lateral sclerosis	0.000142	0.00777	CbGeAlD
Dexamethasone—CYP19A1—central nervous system—amyotrophic lateral sclerosis	0.000142	0.00775	CbGeAlD
Dexamethasone—CYP1B1—nervous system—amyotrophic lateral sclerosis	0.000138	0.00753	CbGeAlD
Dexamethasone—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000137	0.00746	CbGeAlD
Dexamethasone—NR3C2—brain—amyotrophic lateral sclerosis	0.000135	0.00736	CbGeAlD
Dexamethasone—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000134	0.00734	CbGeAlD
Dexamethasone—CYP1B1—central nervous system—amyotrophic lateral sclerosis	0.000133	0.00725	CbGeAlD
Dexamethasone—CYP1B1—cerebellum—amyotrophic lateral sclerosis	0.00013	0.00709	CbGeAlD
Dexamethasone—NR3C1—medulla oblongata—amyotrophic lateral sclerosis	0.000126	0.00687	CbGeAlD
Dexamethasone—PGR—brain—amyotrophic lateral sclerosis	0.000125	0.00684	CbGeAlD
Dexamethasone—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000122	0.00665	CbGeAlD
Dexamethasone—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000118	0.00646	CbGeAlD
Dexamethasone—SLCO1A2—brain—amyotrophic lateral sclerosis	0.000116	0.00631	CbGeAlD
Dexamethasone—CYP19A1—brain—amyotrophic lateral sclerosis	0.000113	0.00616	CbGeAlD
Dexamethasone—NR3C1—spinal cord—amyotrophic lateral sclerosis	0.000112	0.00613	CbGeAlD
Dexamethasone—PTGS2—medulla oblongata—amyotrophic lateral sclerosis	0.000109	0.00595	CbGeAlD
Dexamethasone—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000106	0.00576	CbGeAlD
Dexamethasone—ABCB1—embryo—amyotrophic lateral sclerosis	0.000105	0.00576	CbGeAlD
Dexamethasone—CYP1B1—brain—amyotrophic lateral sclerosis	0.000105	0.00576	CbGeAlD
Dexamethasone—CYP1A1—nervous system—amyotrophic lateral sclerosis	9.75e-05	0.00532	CbGeAlD
Dexamethasone—PTGS2—spinal cord—amyotrophic lateral sclerosis	9.72e-05	0.0053	CbGeAlD
Dexamethasone—ABCG2—cerebellum—amyotrophic lateral sclerosis	9.67e-05	0.00528	CbGeAlD
Dexamethasone—CYP2B6—nervous system—amyotrophic lateral sclerosis	9.48e-05	0.00517	CbGeAlD
Dexamethasone—NR3C1—nervous system—amyotrophic lateral sclerosis	9.46e-05	0.00516	CbGeAlD
Dexamethasone—CYP1A1—central nervous system—amyotrophic lateral sclerosis	9.39e-05	0.00512	CbGeAlD
Dexamethasone—CYP2B6—central nervous system—amyotrophic lateral sclerosis	9.12e-05	0.00498	CbGeAlD
Dexamethasone—NR3C1—central nervous system—amyotrophic lateral sclerosis	9.11e-05	0.00497	CbGeAlD
Dexamethasone—NR3C1—cerebellum—amyotrophic lateral sclerosis	8.9e-05	0.00486	CbGeAlD
Dexamethasone—CYP2E1—nervous system—amyotrophic lateral sclerosis	8.89e-05	0.00485	CbGeAlD
Dexamethasone—CYP2E1—central nervous system—amyotrophic lateral sclerosis	8.56e-05	0.00467	CbGeAlD
Dexamethasone—CYP2E1—cerebellum—amyotrophic lateral sclerosis	8.37e-05	0.00457	CbGeAlD
Dexamethasone—PTGS2—nervous system—amyotrophic lateral sclerosis	8.19e-05	0.00447	CbGeAlD
Dexamethasone—CYP2C8—brain—amyotrophic lateral sclerosis	8.07e-05	0.00441	CbGeAlD
Dexamethasone—PTGS2—central nervous system—amyotrophic lateral sclerosis	7.88e-05	0.0043	CbGeAlD
Dexamethasone—ABCG2—brain—amyotrophic lateral sclerosis	7.85e-05	0.00429	CbGeAlD
Dexamethasone—PTGS2—cerebellum—amyotrophic lateral sclerosis	7.71e-05	0.00421	CbGeAlD
Dexamethasone—Triamcinolone—PTGS2—amyotrophic lateral sclerosis	7.58e-05	0.0808	CrCbGaD
Dexamethasone—CYP1A1—brain—amyotrophic lateral sclerosis	7.45e-05	0.00407	CbGeAlD
Dexamethasone—CYP2B6—brain—amyotrophic lateral sclerosis	7.24e-05	0.00395	CbGeAlD
Dexamethasone—NR3C1—brain—amyotrophic lateral sclerosis	7.23e-05	0.00395	CbGeAlD
Dexamethasone—CYP3A4—nervous system—amyotrophic lateral sclerosis	7.16e-05	0.00391	CbGeAlD
Dexamethasone—CYP2D6—nervous system—amyotrophic lateral sclerosis	7.04e-05	0.00384	CbGeAlD
Dexamethasone—CYP3A4—central nervous system—amyotrophic lateral sclerosis	6.89e-05	0.00376	CbGeAlD
Dexamethasone—CYP2E1—brain—amyotrophic lateral sclerosis	6.8e-05	0.00371	CbGeAlD
Dexamethasone—CYP2D6—central nervous system—amyotrophic lateral sclerosis	6.78e-05	0.0037	CbGeAlD
Dexamethasone—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	6.74e-05	0.00368	CbGeAlD
Dexamethasone—CYP2D6—cerebellum—amyotrophic lateral sclerosis	6.63e-05	0.00362	CbGeAlD
Dexamethasone—PTGS2—brain—amyotrophic lateral sclerosis	6.26e-05	0.00342	CbGeAlD
Dexamethasone—Betamethasone—PTGS2—amyotrophic lateral sclerosis	6.21e-05	0.0662	CrCbGaD
Dexamethasone—ABCB1—spinal cord—amyotrophic lateral sclerosis	6.01e-05	0.00328	CbGeAlD
Dexamethasone—CYP2D6—brain—amyotrophic lateral sclerosis	5.38e-05	0.00294	CbGeAlD
Dexamethasone—ABCB1—nervous system—amyotrophic lateral sclerosis	5.06e-05	0.00276	CbGeAlD
Dexamethasone—ABCB1—central nervous system—amyotrophic lateral sclerosis	4.88e-05	0.00266	CbGeAlD
Dexamethasone—ABCB1—cerebellum—amyotrophic lateral sclerosis	4.77e-05	0.0026	CbGeAlD
Dexamethasone—ABCB1—brain—amyotrophic lateral sclerosis	3.87e-05	0.00211	CbGeAlD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	1.21e-05	0.000271	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—GSR—amyotrophic lateral sclerosis	1.19e-05	0.000267	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	1.18e-05	0.000266	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	1.18e-05	0.000266	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	1.18e-05	0.000265	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	1.18e-05	0.000265	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.17e-05	0.000264	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.17e-05	0.000263	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.17e-05	0.000263	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	1.16e-05	0.000261	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.16e-05	0.00026	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	1.16e-05	0.00026	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	1.16e-05	0.00026	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.15e-05	0.000259	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	1.15e-05	0.000258	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	1.13e-05	0.000255	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.13e-05	0.000254	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—APOE—amyotrophic lateral sclerosis	1.13e-05	0.000254	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.12e-05	0.000253	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.12e-05	0.000252	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	1.11e-05	0.00025	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	1.11e-05	0.000249	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.1e-05	0.000248	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.09e-05	0.000245	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	1.09e-05	0.000245	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	1.09e-05	0.000245	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	1.08e-05	0.000244	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.08e-05	0.000243	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	1.08e-05	0.000243	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	1.08e-05	0.000243	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	1.08e-05	0.000243	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.08e-05	0.000243	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	1.07e-05	0.000241	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	1.07e-05	0.00024	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.06e-05	0.000239	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	1.06e-05	0.000239	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.06e-05	0.000238	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	1.05e-05	0.000235	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.05e-05	0.000235	CbGpPWpGaD
Dexamethasone—NOS2—Disease—APOE—amyotrophic lateral sclerosis	1.04e-05	0.000233	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.03e-05	0.000232	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	1.03e-05	0.00023	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	1.03e-05	0.00023	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.02e-05	0.00023	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.01e-05	0.000228	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.01e-05	0.000226	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.01e-05	0.000226	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	9.97e-06	0.000224	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	9.88e-06	0.000222	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.83e-06	0.000221	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	9.83e-06	0.000221	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	9.76e-06	0.000219	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.61e-06	0.000216	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	9.6e-06	0.000216	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.57e-06	0.000215	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	9.51e-06	0.000214	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.47e-06	0.000213	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	9.47e-06	0.000213	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	9.42e-06	0.000212	CbGpPWpGaD
Dexamethasone—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.3e-06	0.000209	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.27e-06	0.000208	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.25e-06	0.000208	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	9.25e-06	0.000208	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.19e-06	0.000206	CbGpPWpGaD
Dexamethasone—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.17e-06	0.000206	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	9.14e-06	0.000205	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.99e-06	0.000202	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	8.94e-06	0.000201	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.91e-06	0.0002	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.88e-06	0.0002	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	8.88e-06	0.0002	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—APOE—amyotrophic lateral sclerosis	8.88e-06	0.0002	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	8.87e-06	0.000199	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	8.8e-06	0.000198	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—TP53—amyotrophic lateral sclerosis	8.72e-06	0.000196	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	8.71e-06	0.000196	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	8.67e-06	0.000195	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	8.64e-06	0.000194	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	8.59e-06	0.000193	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	8.57e-06	0.000193	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	8.41e-06	0.000189	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.4e-06	0.000189	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	8.4e-06	0.000189	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	8.36e-06	0.000188	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.33e-06	0.000187	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.26e-06	0.000186	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	8.25e-06	0.000185	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.23e-06	0.000185	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.14e-06	0.000183	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	8.07e-06	0.000181	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	7.99e-06	0.00018	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.94e-06	0.000178	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.94e-06	0.000178	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	7.93e-06	0.000178	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	7.93e-06	0.000178	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	7.88e-06	0.000177	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	7.81e-06	0.000176	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	7.77e-06	0.000175	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	7.75e-06	0.000174	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.73e-06	0.000174	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.56e-06	0.00017	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.51e-06	0.000169	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.48e-06	0.000168	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	7.32e-06	0.000165	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	7.27e-06	0.000163	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.22e-06	0.000162	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	7.19e-06	0.000162	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	7.13e-06	0.00016	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	7.13e-06	0.00016	CbGpPWpGaD
Dexamethasone—NOS2—Disease—PTGS2—amyotrophic lateral sclerosis	7.09e-06	0.000159	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.01e-06	0.000158	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	6.83e-06	0.000153	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—APOE—amyotrophic lateral sclerosis	6.8e-06	0.000153	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.79e-06	0.000153	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	6.77e-06	0.000152	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	6.71e-06	0.000151	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	6.67e-06	0.00015	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.67e-06	0.00015	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.64e-06	0.000149	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	6.52e-06	0.000146	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	6.51e-06	0.000146	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	6.49e-06	0.000146	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.39e-06	0.000144	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	6.38e-06	0.000143	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	6.36e-06	0.000143	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.34e-06	0.000142	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	6.34e-06	0.000142	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—APOE—amyotrophic lateral sclerosis	6.22e-06	0.00014	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.18e-06	0.000139	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—APOE—amyotrophic lateral sclerosis	6.16e-06	0.000138	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.11e-06	0.000137	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.11e-06	0.000137	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.1e-06	0.000137	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.09e-06	0.000137	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.06e-06	0.000136	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	6.04e-06	0.000136	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.03e-06	0.000136	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	6.01e-06	0.000135	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	5.99e-06	0.000135	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	5.97e-06	0.000134	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	5.92e-06	0.000133	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	5.85e-06	0.000131	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.78e-06	0.00013	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	5.7e-06	0.000128	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	5.66e-06	0.000127	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.64e-06	0.000127	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.54e-06	0.000125	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	5.51e-06	0.000124	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	5.51e-06	0.000124	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.49e-06	0.000123	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	5.46e-06	0.000123	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—APOE—amyotrophic lateral sclerosis	5.46e-06	0.000123	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.46e-06	0.000123	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.45e-06	0.000122	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.25e-06	0.000118	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.25e-06	0.000118	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.19e-06	0.000117	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	5.15e-06	0.000116	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.03e-06	0.000113	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.01e-06	0.000113	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.98e-06	0.000112	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	4.96e-06	0.000112	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	4.92e-06	0.000111	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.82e-06	0.000108	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	4.8e-06	0.000108	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.77e-06	0.000107	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.73e-06	0.000106	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.66e-06	0.000105	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—APOE—amyotrophic lateral sclerosis	4.56e-06	0.000102	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	4.53e-06	0.000102	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.49e-06	0.000101	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	4.49e-06	0.000101	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.39e-06	9.86e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.35e-06	9.77e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.34e-06	9.76e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.34e-06	9.75e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	4.28e-06	9.62e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.26e-06	9.58e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	4.25e-06	9.55e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.22e-06	9.48e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—APOE—amyotrophic lateral sclerosis	4.12e-06	9.26e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.09e-06	9.2e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.99e-06	8.96e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—APOE—amyotrophic lateral sclerosis	3.97e-06	8.92e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.92e-06	8.81e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.9e-06	8.77e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.76e-06	8.45e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.74e-06	8.41e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.64e-06	8.18e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	3.61e-06	8.11e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	3.6e-06	8.1e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	3.58e-06	8.04e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.5e-06	7.87e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.45e-06	7.75e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.43e-06	7.7e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.42e-06	7.69e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.35e-06	7.52e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.34e-06	7.51e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	3.29e-06	7.39e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	3.28e-06	7.37e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.23e-06	7.26e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.22e-06	7.23e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.16e-06	7.1e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.15e-06	7.08e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.14e-06	7.06e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.12e-06	7.02e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.08e-06	6.91e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.97e-06	6.67e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.96e-06	6.66e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.96e-06	6.65e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.84e-06	6.37e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.82e-06	6.34e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.8e-06	6.3e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	2.75e-06	6.19e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.72e-06	6.12e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.72e-06	6.11e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	2.65e-06	5.95e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.64e-06	5.94e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	2.59e-06	5.82e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	2.59e-06	5.81e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.58e-06	5.8e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.47e-06	5.56e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.45e-06	5.51e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	2.44e-06	5.49e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.43e-06	5.47e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.43e-06	5.46e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.41e-06	5.42e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.37e-06	5.33e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.25e-06	5.05e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	2.24e-06	5.03e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.24e-06	5.02e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.22e-06	4.98e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.14e-06	4.82e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	2e-06	4.49e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	1.95e-06	4.39e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.84e-06	4.13e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.82e-06	4.1e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.81e-06	4.07e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.78e-06	3.99e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.77e-06	3.98e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.67e-06	3.76e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.59e-06	3.57e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.53e-06	3.45e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.46e-06	3.28e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.37e-06	3.08e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.34e-06	3.01e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.26e-06	2.83e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.25e-06	2.81e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.2e-06	2.7e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.24e-07	1.85e-05	CbGpPWpGaD
